EU Hantavirus drug Favipiravir

EU Distributes Experimental Drug to Combat Hantavirus Outbreak

The European Union dispatched experimental Hantavirus drugs today. Officials sent the medication to France, Spain, and the Netherlands.

The urgent move aims to contain the deadly disease spread.

Donating Essential Medication

A Japanese company donated 1,400 tablets of Favipiravir. The European Commission made this drug available to member states.

Doctors currently lack any officially approved Hantavirus vaccine or treatment. The European Medicines Agency identified Favipiravir as the best option.

Doctors use it in clinical trials for serious cases.

Emergency Procurement Procedures

Individual countries will decide exactly how they use the medication. The European Commission launched emergency procedures to buy more medicine.

They anticipate rising infection numbers in the coming weeks.

Stay informed on global health emergencies and medical breakthroughs on the Oman Day homepage.

tag: hantavirus , european-union , favipiravir , outbreak , global-health , medical-news , oman-day-international

Author: Amita Kalsi   

 

Share This Post

YOU MAY ALSO LIKE

COMMENTS